SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-127814
Filing Date
2020-04-30
Accepted
2020-04-30 08:55:33
Documents
4
Period of Report
2020-04-30
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d900859d8k.htm 8-K 17622
2 EX-99.1 d900859dex99.htm EX-99 19158
3 GRAPHIC g900859g50i63.jpg GRAPHIC 3504
4 GRAPHIC g900859g63d42.jpg GRAPHIC 67245
  Complete submission text file 0001193125-20-127814.txt   135717
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31791 | Film No.: 20833415
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences